Dr. Charla Burns, MD Appointed to the Advisory Council of Cummings Graduate Institute for Behavioral Health StudiesThe nonprofit, private, post-secondary institution specializing in integrated behavioral health education welcomes Dr. Charla Burns to the CGI Advisory Council.
Dr. Charla Burns is a physician and epidemiologist currently serving as the Multisystem Inflammatory Syndrome in Children (MIS-C) Team Lead at the Texas Department of State Health Services. Prior to her current role, Dr. Burns was a COVID-19 Epidemiologist at the CDC Foundation. Dr. Burns completed her Bachelor of Science in Biochemistry/ Dr. U. Grant Baldwin, Jr. DBH, the Assistant Director of Academic Programs at Cummings Graduate Institute for Behavioral Health Studies, shares, "I am absolutely elated about Dr. Burn's appointment. Her experience, skills and leadership will further strengthen the insight of our advisory council and leadership. Dr. Burns will certainly broaden our medical education scope and support our health equity efforts at CGI as we continue to cultivate leading voices in healthcare transformation and innovation." The Advisory Council is integral in improving and shaping existing curricula, identifying gaps in education and training, developing and promoting workforce development and continuing education, and identifying and advocating for essential industry and educational partnerships for CGI. Cummings Graduate Institute for Behavioral Health Studies is thrilled to welcome Dr. Charla Burns to the Advisory Council. About Cummings Graduate Institute for Behavioral Health Studies Cummings Graduate Institute for Behavioral Health Studies, a private, nonprofit, DEAC accredited institution, offers education and training in integrated behavioral healthcare through a virtual online campus. To learn more about Cummings Graduate Institute for Behavioral Health Studies, visit https://cgi.edu/ Contact Jacqueline Carro, Marketing & PR ***@marketingideals.com Photo: https://www.prlog.org/ End
Account Email Address Account Phone Number Disclaimer Report Abuse Page Updated Last on: Jan 03, 2023
|